MolDX: DecisionDx-UM (Uveal Melanoma)

This contractor provides limited coverage for the DecisionDx-UM test for management of newly diagnosed uveal melanoma to determine metastatic risk and to guide surveillance and referral to medical oncology. Coverage is restricted to patients with a confirmed diagnosis of uveal melanoma and no evidence of metastatic disease, and is intended to inform follow-up and oncology referral decisions.

"DecisionDx-UM is covered for management of newly diagnosed uveal melanoma to determine metastatic risk."

Sign up to see full coverage criteria, indications, and limitations.